Clinical Trial Update: Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of sofosbuvir plus ribavirin in treatment-naive adults with chronic genotype 1 or genotype 3 hepatitis C infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic HCV Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-10-25